HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B Malavaud Selected Research
B Malavaud Research Topics
Disease
8
Prostatic Neoplasms (Prostate Cancer)
09/2016 - 03/2000
8
Neoplasms (Cancer)
03/2016 - 01/2000
4
Urinary Incontinence
09/2015 - 04/2001
4
Urinary Tract Infections (Urinary Tract Infection)
09/2015 - 01/2000
4
Overactive Urinary Bladder (Overactive Bladder)
09/2013 - 07/2008
4
Infections
06/2008 - 01/2000
3
Hypoxia (Hypoxemia)
06/2016 - 03/2016
3
Urinary Bladder Neoplasms (Bladder Cancer)
03/2010 - 01/2001
3
Erectile Dysfunction
10/2001 - 05/2000
2
Renal Insufficiency (Renal Failure)
01/2017 - 05/2010
2
Atrophy
09/2015 - 06/2013
2
Margins of Excision
07/2012 - 10/2008
2
Neoplasm Metastasis (Metastasis)
10/2008 - 04/2000
1
Ileus
01/2017
1
Malnutrition (Nutritional Deficiencies)
01/2017
1
Breast Neoplasms (Breast Cancer)
09/2015
1
Thrombosis (Thrombus)
09/2015
1
Endometrial Neoplasms (Endometrial Cancer)
09/2015
1
Dyspareunia
09/2015
1
Non-Muscle Invasive Bladder Neoplasms
04/2015
1
Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
09/2013
1
Inflammation (Inflammations)
06/2013
1
Hypertrophy
03/2013
1
Hyperplasia
03/2013
1
Shock
10/2012
1
Renal Colic
10/2012
1
Urinary Retention
07/2012
1
Neural Tube Defects (Exencephaly)
05/2010
1
Renal Cell Carcinoma (Grawitz Tumor)
03/2010
1
Cross Infection (Nosocomial Infection)
06/2008
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2008
1
Delayed Graft Function
12/2005
1
Lymphocele
12/2005
1
Necrosis
10/2003
1
Fistula
10/2003
1
Crohn Disease (Crohn's Disease)
10/2003
1
Virus Diseases (Viral Diseases)
03/2000
Drug/Important Bio-Agent (IBA)
2
Androgen Receptors (Androgen Receptor)
IBA
06/2016 - 03/2016
2
sphingosine kinase
IBA
03/2016 - 05/2008
2
Estrogens (Estrogen)
FDA Link
09/2015 - 06/2013
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2000 - 01/2000
1
Transcription Factors (Transcription Factor)
IBA
03/2016
1
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
03/2016
1
Oxygen (Dioxygen)
IBA
03/2016
1
Biological Products
IBA
03/2016
1
Acids
IBA
04/2015
1
5-aminolevulinic acid hexyl ester
FDA Link
04/2015
1
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
09/2013
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
09/2013
1
Adrenergic Agents (Adrenergic Drugs)
IBA
06/2013
1
Estradiol (Delestrogen)
FDA Link
Generic
06/2013
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
06/2013
1
Cholinergic Agents (Cholinergics)
IBA
06/2013
1
Biomarkers (Surrogate Marker)
IBA
03/2011
1
Genetic Markers (Genetic Marker)
IBA
12/2010
1
Prostate-Specific Antigen (Semenogelase)
IBA
07/2009
1
Dihydrotachysterol (AT 10)
IBA
10/2008
1
Type A Botulinum Toxins (Botox)
FDA Link
07/2008
1
Botulinum Toxins (Botulinum Toxin)
IBA
07/2008
1
Cholinergic Antagonists (Anticholinergics)
IBA
07/2008
1
Anti-Bacterial Agents (Antibiotics)
IBA
06/2008
1
Sphingosine
IBA
05/2008
1
F 12509A
IBA
05/2008
1
Phosphates (Orthophosphate)
IBA
05/2008
1
Ceramides
IBA
05/2008
1
Imatinib Mesylate (Gleevec)
FDA Link
05/2008
1
Protons (Proton)
IBA
12/2004
1
Gadolinium
IBA
12/2004
1
Infliximab (Remicade)
FDA Link
10/2003
1
Sildenafil Citrate (Viagra)
FDA Link
10/2001
1
Collagen
IBA
04/2001
1
Peptides (Polypeptides)
IBA
04/2000
1
Phosphotransferases (Kinase)
IBA
04/2000
1
RNA (Ribonucleic Acid)
IBA
03/2000
1
Antigens
IBA
03/2000
1
Indinavir (Crixivan)
FDA Link
03/2000
Therapy/Procedure
4
Prostatectomy (Retropubic Prostatectomy)
12/2012 - 03/2000
3
Kidney Transplantation
05/2010 - 05/2000
3
Therapeutics
03/2010 - 01/2000
3
Cystectomy
03/2010 - 01/2001
2
Castration
06/2016 - 03/2016
2
Nephrectomy
03/2013 - 07/2012
2
Urinary Diversion (Ileal Conduit)
02/2009 - 01/2001
2
Injections
07/2008 - 04/2001
1
Blood Transfusion (Blood Transfusions)
01/2017
1
Extracorporeal Shockwave Therapy
09/2016
1
Stents
10/2012
1
Catheters
07/2012
1
Institutionalization (Institutionalized Persons)
01/2011
1
Length of Stay
03/2010
1
Immunotherapy
03/2010
1
Conservative Treatment
03/2010
1
Drug Therapy (Chemotherapy)
03/2010
1
Adjuvant Radiotherapy
10/2008
1
Duration of Therapy
06/2008
1
Critical Care (Surgical Intensive Care)
06/2008
1
Renal Dialysis (Hemodialysis)
12/2005
1
Patient Readmission
12/2005
1
Vascular Surgical Procedures
08/2001
1
Operative Surgical Procedures
01/2001